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Letters to the Editorthat ligation of a single pulmonary
vein, either superior or inferior, may
be accompanied by dilation of collat-
eral veins to the azygous system,which
may be compatiblewith life.4 This area
requires further study, and conclusions
should not be based a single case.
In surgical emergencies, a transected
main pulmonary artery does not pre-
clude abrupt abortion of the intended
surgical procedure. However, this
should be used as a last resort. In elec-
tive cancer cases, a thorough inspection
of all structures including artery, veins,
and bronchus should be undertaken to
ensure resectability before transection
of any individual major structure.
Raja M. Flores, MD
Chief of Thoracic Surgery
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To the Editor:
In their recent article, Salazar and
colleagues1 have rightly addressed
a pertinent topic. We agree that under
usual circumstances a fenestration at
the time of a total cavopulmonary
connection should be avoided. Be-
tween June 2000 and June 2006, a total
of 132 consecutive patients were
treated at our institution without any
fenestrations. At the time of total cav-
opulmonary connection, 93 patients
(70%) were younger than 48 months.
We continue to complete at a young598 The Journal of Thoracic and Cage and to avoid fenestrations. We
have since opted for fenestration in
only 2 patients, both of whom under-
went single-lung palliation.
Salazar and colleagues1 state that
they opted for fenestration only in
‘‘highly selected patients.’’ They men-
tion patients with elevated pulmonary
vascular resistance or transpulmonary
gradient, significant atrioventricular re-
gurgitation, and single-lung physiol-
ogy. We would appreciate further
guidance on their selection criteria, be-
cause we would like to know their cut-
off for elevated pulmonary vascular
resistance and why they deem patients
with atrioventricular regurgitation to
be candidates for fenestration. In addi-
tion, why should any intracardiac anat-
omynot be amenable to an extracardiac
completion? In our view, the extracar-
diac completion does in fact help to
overcome many complex morphologic
obstacles and helps make it quite easy
to reroute central venous blood flow
to the pulmonary vascular bed.
Salazar and colleagues1 might also
elucidate their experience with fenes-
tration patency. Ruiz and colleagues2
have published an intriguing concept
in which the lower atrial orifice toward
the divided inferior vena cava is su-
tured in an end-to-side fashion to the
leftward aspect of thepunched conduit.
Christian Schreiber, MD, PhD
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HYPERLACTATEMIA AFTER
SURGICAL REPAIR OF
SECUNDUM ATRIAL SEPTAL
DEFECT IN CHILDREN: WHAT
IS THE PROBLEM?
To the Editor:
We read with great interest the arti-
cle by Abraham and colleagues.1 They
report their results of a retrospective
study on the intraoperative risk factors
for early postoperative hyperlactate-
mia in patients undergoing atrial sep-
tal defect repair. Multivariate logistic
regression analysis showed that lower
cardiopulmonary bypass (CPB) flow
rate is an independent risk factor for
early postoperative hyperlactatemia
in children after atrial septal defect re-
pair. It has instructive significance for
the perfusionist to maintain higher
mixed venous saturations and use va-
sodilators during CPB to improve
overall tissue perfusion.
The study includes 68 patients with
atrial septal defect, Risk Adjustment
for Congenital Heart Surgery category
I, who had good cardiac output in the
postoperative period. This effectively
avoids the influence of confounding
factors on blood lactate, such as the
CPB temperature, hemodilution, du-
ration of CPB, cardiac function, drugs
used perioperatively, liver and kidney
function, and so forth. The design is
a benefit for the study of the correla-
tion simply between intraoperative
factors and postoperative hyperlacta-
temia. However, several other factors
that influence the blood lactate should
be considered.
The subjects have atrial septal de-
fect and are aged less than 21 years
(range, 5–201 months). The age span
is comparatively large because there
is a big difference in the CPB prime
and management between those aged
5 months and those aged 201 months.
Generally, children aged less than 1
year would be primed with banked
red blood cells and have compara-
tively more banked blood periopera-
tively. Banked blood itself, which
